Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry

Table 3

Cumulative major adverse cardiac events at 30-day, 6-month, and 9-month follow-up.

Clinical outcomes	30-day follow-up	6-month follow-up	9-month follow-up
Death, (%)	0 (0%)	0 (0%)	0 (0%)
Myocardial infarction, (%)	0 (0%)	1 (0.3%)	2 (0.5%)
Q-wave, (%)	0 (0%)	0 (0%)	1 (0.3%)
Non-Q-wave, (%)	0 (0%)	1 (0.3%)	1 (0.3%)
Target lesion revascularization, (%)	0 (0%)	3 (0.8%)	4 (1.1%)
Target vessel revascularization, (%)	0 (0%)	0 (0%)	0 (0%)
Stent thrombosis, (%)	0 (0%)	2 (0.5%)	2 (0.5%)
MACE, (%)	0 (0%)	6 (1.6%)	8 (2.2%)